Literature DB >> 19644590

Optimal biphasic waveforms for internal defibrillation using a 60 muF capacitor.

Yoshio Yamanouchi1, Stéphane X Garrigue, Kent A Mowrey, Bruce L Wilkoff, Patrick J Tchou.   

Abstract

The optimal capacitance for defibrillation is calculated to be 40 to 80 muF by theoretical models, assuming a heart chronaxie of 2 to 4 ms and a mean impedance of 40 ohms. The 60 muF capacitor is optimal for providing maximum defibrillation efficacy, which can reduce defibrillation energy. The purpose of the present study was to determine the optimal tilt to maximize defibrillation efficacy in a 60/60 muF biphasic waveform and to compare these waveforms with an optimized 60/15 muF waveform. The defibrillation thresholds (DFTs) were evaluated for five different 60/60 muF biphasic waveforms having 40%, 50%, 60%, 70% and 80% phase 1 tilt and a 60/15 muF biphasic waveform having 50% phase 1 tilt with a hot can electrode system in 15 pigs (20+/-2 kg). Phase 2 pulse widths were held constant at 3 ms in all waveforms. The DFT was measured by 'down-up, down-up' technique and was random in each waveform. The DFT energy in 60/60 muF waveforms (40%, 50%, 60%, 70% and 80%) and a 60/15 muF waveform (50%) were 6.9*, 6.9*, 7.1*, 7.8*, 8.4* and 6.0, respectively (*P<0.05 versus 60/15 muF waveform). A phase 1 tilt of 40% to 50% maximizes defibrillation efficacy for biphasic waveforms using 60/60 muF capacitors. Additionally, switching to a 15 muF capacitor for phase 2 can further reduce the DFT energy.

Entities:  

Keywords:  Biphasic waveform; Internal defibrillation; Small capacitor

Year:  2002        PMID: 19644590      PMCID: PMC2716990     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  38 in total

1.  Smaller capacitors improve the biphasic waveform.

Authors:  K Rist; P J Tchou; K Mowrey; M W Kroll; J E Brewer
Journal:  J Cardiovasc Electrophysiol       Date:  1994-09

Review 2.  Mechanisms of defibrillation for monophasic and biphasic waveforms.

Authors:  G P Walcott; K T Walcott; S B Knisley; X Zhou; R E Ideker
Journal:  Pacing Clin Electrophysiol       Date:  1994-03       Impact factor: 1.976

3.  Effects of polarity on defibrillation thresholds using a biphasic waveform in a hot can electrode system.

Authors:  Y Yamanouchi; K A Mowrey; G R Nadzam; D G Hills; M W Kroll; J E Brewer; A M Donohoo; B L Wilkoff; P J Tchou
Journal:  Pacing Clin Electrophysiol       Date:  1997-12       Impact factor: 1.976

4.  Charge-burping theory correctly predicts optimal ratios of phase duration for biphasic defibrillation waveforms.

Authors:  C D Swerdlow; W Fan; J E Brewer
Journal:  Circulation       Date:  1996-11-01       Impact factor: 29.690

5.  Effect of changing capacitors between phases of a biphasic defibrillation shock.

Authors:  G P Walcott; D L Rollins; W M Smith; R E Ideker
Journal:  Pacing Clin Electrophysiol       Date:  1996-06       Impact factor: 1.976

6.  Ventricular defibrillation using biphasic waveforms: the importance of phasic duration.

Authors:  A S Tang; S Yabe; J M Wharton; M Dolker; W M Smith; R E Ideker
Journal:  J Am Coll Cardiol       Date:  1989-01       Impact factor: 24.094

7.  Comparison of biphasic and monophasic shocks for defibrillation using a nonthoracotomy system.

Authors:  D G Wyse; K M Kavanagh; A M Gillis; L B Mitchell; H J Duff; R S Sheldon; T M Kieser; A Maitland; P Flanagan; J Rothschild
Journal:  Am J Cardiol       Date:  1993-01-15       Impact factor: 2.778

Review 8.  Mechanisms of electrical defibrillation: impact of new experimental defibrillator waveforms.

Authors:  S M Blanchard; R E Ideker
Journal:  Am Heart J       Date:  1994-04       Impact factor: 4.749

9.  Effect of waveform tilt on defibrillation thresholds in humans.

Authors:  S R Shorofsky; A H Foster; M R Gold
Journal:  J Cardiovasc Electrophysiol       Date:  1997-05

10.  Application of models of defibrillation to human defibrillation data: implications for optimizing implantable defibrillator capacitance.

Authors:  C D Swerdlow; J E Brewer; R M Kass; M W Kroll
Journal:  Circulation       Date:  1997-11-04       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.